Exact Mass: 429.2376
Exact Mass Matches: 429.2376
Found 91 metabolites which its exact mass value is equals to given mass value 429.2376,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Melagatran
SCHEMBL8083301
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AE - Direct thrombin inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173066 - Direct Thrombin Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins
Melagatran
2-{[2-(2-{[(4-carbamimidoylphenyl)methyl]carbamoyl}azetidin-1-yl)-1-cyclohexyl-2-oxoethyl]amino}acetic acid
Ala Pro Arg Ser
(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid
Ala Pro Ser Arg
(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid
Ala Arg Pro Ser
(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid
Ala Arg Ser Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid
Ala Ser Pro Arg
(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid
Ala Ser Arg Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid
Gly Pro Arg Thr
(2S,3R)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid
Gly Pro Thr Arg
(2S)-2-[(2S,3R)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid
Gly Arg Pro Thr
(2S,3R)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid
Gly Arg Thr Pro
(2S)-1-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid
Gly Thr Pro Arg
(2S)-2-{[(2S)-1-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid
Gly Thr Arg Pro
(2S)-1-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid
Pro Ala Arg Ser
(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]-3-hydroxypropanoic acid
Pro Ala Ser Arg
(2S)-5-carbamimidamido-2-[(2S)-3-hydroxy-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]pentanoic acid
Pro Gly Arg Thr
(2S,3R)-2-[(2S)-5-carbamimidamido-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]-3-hydroxybutanoic acid
Pro Gly Thr Arg
(2S)-5-carbamimidamido-2-[(2S,3R)-3-hydroxy-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]pentanoic acid
Pro Arg Ala Ser
(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]-3-hydroxypropanoic acid
Pro Arg Gly Thr
(2S,3R)-2-{2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}-3-hydroxybutanoic acid
Pro Arg Ser Ala
(2S)-2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-hydroxypropanamido]propanoic acid
Pro Arg Thr Gly
2-[(2S,3R)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]-3-hydroxybutanamido]acetic acid
Pro Ser Ala Arg
(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]pentanoic acid
Pro Ser Arg Ala
(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]propanoic acid
Pro Thr Gly Arg
(2S)-5-carbamimidamido-2-{2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}pentanoic acid
Pro Thr Arg Gly
2-[(2S)-5-carbamimidamido-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]pentanamido]acetic acid
Arg Ala Pro Ser
(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid
Arg Ala Ser Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid
Arg Gly Pro Thr
(2S,3R)-2-{[(2S)-1-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetyl}pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid
Arg Gly Thr Pro
(2S)-1-[(2S,3R)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid
Arg Pro Ala Ser
(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-hydroxypropanoic acid
Arg Pro Gly Thr
(2S,3R)-2-(2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-hydroxybutanoic acid
Arg Pro Ser Ala
(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]propanoic acid
Arg Pro Thr Gly
2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]acetic acid
Arg Ser Ala Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]propanoyl]pyrrolidine-2-carboxylic acid
Arg Ser Pro Ala
(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}propanoic acid
Arg Thr Gly Pro
(2S)-1-{2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]acetyl}pyrrolidine-2-carboxylic acid
Arg Thr Pro Gly
2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}acetic acid
Ser Ala Pro Arg
(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid
Ser Ala Arg Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid
Ser Pro Ala Arg
(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}propanamido]-5-carbamimidamidopentanoic acid
Ser Pro Arg Ala
(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]propanoic acid
Ser Arg Ala Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]propanoyl]pyrrolidine-2-carboxylic acid
Ser Arg Pro Ala
(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}propanoic acid
Thr Gly Pro Arg
(2S)-2-{[(2S)-1-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetyl}pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid
Thr Gly Arg Pro
(2S)-1-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid
Thr Pro Gly Arg
(2S)-2-(2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}acetamido)-5-carbamimidamidopentanoic acid
Thr Pro Arg Gly
2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]acetic acid
Thr Arg Gly Pro
(2S)-1-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]acetyl}pyrrolidine-2-carboxylic acid
Thr Arg Pro Gly
2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetic acid
1-(4-Diethylaminophenyl)-1,4,4-triphenyl-1,3-butadiene
1-(4-Diethylaminophenyl)-1,4,4-triphenyl-1,3-butadiene
1-(2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ETHYL)-1H-1,2,3-TRIAZOLE-4-CARBOTHIALDEHYDE
1-(2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENOXY)ETHYL)-1H-1,2,3-TRIAZOLE-4-CARBOTHIALDEHYDE
(2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-N-[(1S)-1-cyclohexylethyl]pyrrolidine-1-carboxamide
(2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-N-[(1S)-1-cyclohexylethyl]pyrrolidine-1-carboxamide
ON-123300
ON-123300
Narazaciclib (ON123300), a strong and brain-penetrant[1] multi-kinase inhibitor, inhibits CDK4 (IC50=3.9 nM), Ark5 (IC50=5 nM), PDGFRβ (IC50=26 nM), FGFR1 (IC50=26 nM), RET (IC50=9.2 nM), and FYN (IC50=11 nM). Single agent Narazaciclib causes a dose-dependent suppression of phosphorylation of Akt as well as activation of Erk in brain tumors[2]. Narazaciclib inhibits CDK6 with an IC50 of 9.82 nM[3].
N-[(3-acetamidophenyl)methyl]-1-[(1R)-1-naphthalen-1-ylethyl]piperidine-4-carboxamide
N-[(3-acetamidophenyl)methyl]-1-[(1R)-1-naphthalen-1-ylethyl]piperidine-4-carboxamide
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N-(4-phenylmethoxyphenyl)-3-[4-(phenylmethyl)-1-piperazinyl]propanamide
N-(4-phenylmethoxyphenyl)-3-[4-(phenylmethyl)-1-piperazinyl]propanamide
[(3aR,4S,9bS)-4-(hydroxymethyl)-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-cyclohexylmethanone
[(3aR,4S,9bS)-4-(hydroxymethyl)-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-cyclohexylmethanone
(2R,3S)-8-(4-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-(4-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
[(3aS,4R,9bR)-4-(hydroxymethyl)-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-cyclohexylmethanone
[(3aS,4R,9bR)-4-(hydroxymethyl)-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-cyclohexylmethanone
[(3aS,4S,9bR)-4-(hydroxymethyl)-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-cyclohexylmethanone
[(3aS,4S,9bR)-4-(hydroxymethyl)-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-cyclohexylmethanone
3-[4-(2-Benzyl-5-tert-butylpyrazole-3-carbonyl)piperazin-1-yl]pyrazine-2-carbonitrile
3-[4-(2-Benzyl-5-tert-butylpyrazole-3-carbonyl)piperazin-1-yl]pyrazine-2-carbonitrile
asnovolin I(1-)
asnovolin I(1-)
A monocarboxylic acid anion that is the conjugate base of asnovolin I resulting from the deprotonation of the carboxy group. Major microspecies at pH 7.3.
4-[(4'-methoxy-5'-{[(2z)-5-methyl-4-pentylpyrrol-2-ylidene]methyl}-1h,1'h-[2,2'-bipyrrol]-5-yl)methyl]phenol
4-[(4'-methoxy-5'-{[(2z)-5-methyl-4-pentylpyrrol-2-ylidene]methyl}-1h,1'h-[2,2'-bipyrrol]-5-yl)methyl]phenol
4-({4'-methoxy-5'-[(5-methyl-4-pentylpyrrol-2-ylidene)methyl]-1h,1'h-[2,2'-bipyrrol]-5-yl}methyl)phenol
4-({4'-methoxy-5'-[(5-methyl-4-pentylpyrrol-2-ylidene)methyl]-1h,1'h-[2,2'-bipyrrol]-5-yl}methyl)phenol
4-({4'-methoxy-5'-[(5-methyl-4-pentyl-1h-pyrrol-2-yl)methylidene]-1h-[2,2'-bipyrrol]-5-yl}methyl)phenol
4-({4'-methoxy-5'-[(5-methyl-4-pentyl-1h-pyrrol-2-yl)methylidene]-1h-[2,2'-bipyrrol]-5-yl}methyl)phenol
